What about this brain pacemaker Medtronic?

Imported brain pacemakers, the Medtronic Brain Pacemaker is currently used in China.

When it comes to surgical effect, let's analyze the product first.

Medtronic's brain pacemaker was first introduced in 1987, and has been clinically applied for more than 30 years, benefiting 175,000 patients in the world. 1987, Prof. Alim-Louis Benabid and Prof. Pierre Pollak from the University of Grenoble, France, published the first article on the application of brain pacemakers in the treatment of movement disorders. Since then, Medtronic's RC Brain Pacemaker has been progressively approved for four indications. Medtronic's RC pacemaker has the longest FDA/CE/NMPA-approved life span of any pacemaker.

Then again, DBS surgery can improve the symptoms of bradykinesia/motor retardation, muscle stiffness, and tremor in patients with Parkinson's disease, as well as reduce the side effects of medications, depending on a number of factors: a clear diagnosis of Parkinson's disease, appropriate timing of the surgery, multimodal implantation of precise electrodes, standardized postoperative control, and appropriate antitussive therapy. The outcome of DBS surgery depends on several factors: a clear diagnosis of Parkinson's disease, appropriate timing of surgery, precise multimodal electrode implantation, standardized postoperative program control, and a reasonable combination of anti-Parkinson's disease medications. Medtronic pacemakers perform well in all five areas. The high quality, internationally certified electrodes, national gold-medal service, and programmed appointments all provide patients with an excellent experience. The Medtronic Brain Pacemaker is currently used clinically to control symptoms and improve quality of life after surgery, allowing patients to enjoy life again and live a dignified, quality life after surgery.